Tokyo, Aug. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058778) titled 'Genetic Mutation Analysis Using a Comprehensive Cancer Panel for Gastric Lesions in Gastric Polyposis' on Aug. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University Hospital
Condition:
Condition - Patients with Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) or without GAPPS
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to perform comprehensive cancer panel analysis on gastric lesion tissues derived from patients with Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) and, as controls, gastric tissues from non-GAPPS patients, in order to elucidate their genetic mutation profiles.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients who have undergone surgical gastrectomy or endoscopic biopsy, as well as patients scheduled for endoscopic biopsy
Key exclusion criteria - None
Target Size - 20
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 04 Day
Date of IRB - 2025 Year 07 Month 04 Day
Anticipated trial start date - 2025 Year 08 Month 12 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067210
Disclaimer: Curated by HT Syndication.
